Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland
British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2797-2808
DOI: 10.1002/bcp.70543 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 17.04.2026. Verfasst von Fiona A Strobel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Pharmacists, Health Knowledge, Attitudes, Practice, Physicians. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Introduction Reporting adverse drug reactions (ADRs) is essential for detecting drug risks. Despite legal obligations in Switzerland, underreporting remains an issue. This study assessed practice, knowledge and attitudes towards the spontaneous ADR reporting system among physicians and pharmacists.
Methods
A nationwide cross‐sectional survey was disseminated via professional associations to physicians and pharmacists in Switzerland. The 21‐item questionnaire assessed reporting practice, knowledge, attitudes, information needs and improvement suggestions. Multivariable regression (odds ratios [ORs], 95% confidence intervals [95% CIs]) examined associations between participant characteristics and reporting habits.
Results
A total of 1108 participants (834 physicians, 274 pharmacists) were included. ADRs had been suspected by 589 (53.2%), and 562 (50.7%) had reported ≥1 ADR. Most participants rejected the notion that reporting is pointless (999, 90.2%). Although 716 (64.6%) were aware of reporting obligations, 477 (43.1%) perceived reporting as time‐consuming and 270 (24.4%) reported legal concerns. About half indicated no lack of incentives (587, 53.0%) and no concerns regarding personal (580, 52.3%) or patient data protection (545, 49.2%). More than half desired clearer guidance on reportable ADRs (609, 55.0%) and 648 (58.5%) expressed interest in pharmacovigilance training. Reporting ADRs was independently associated with increasing age and training (ORs between 1.28 [95% CI: 1.15, 1.42] and 1.92 [1.32, 2.79]), whereas investing >10 min in reporting was associated with age ≥60 (OR 1.59 [1.07, 2.38]), training (OR 1.28 [1.14, 1.45]) and pharmacist status (OR 1.83 [1.34, 2.51]).
Conclusion
The fundamental willingness to report ADRs despite a simultaneous lack of specific knowledge indicates a need for targeted information campaigns and training opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
- Pharmacovigilance, Safety of Medicines Division, Swissmedic, Swiss Agency for Therapeutic Products, Berne, Switzerland.
- Center for Clinical Research, Lucerne Cantonal Hospital/University of Lucerne, Lucerne, Switzerland.
ORCID-Profile: Fiona A Strobel, Thomas Stammschulte, Patrick E Beeler
Zitieren
APA
Strobel, F. A., Stammschulte, T., & Beeler, P. E. (2026). Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland. British Journal of Clinical Pharmacology, 92(8), 2797-2808. https://doi.org/10.1002/bcp.70543
Vancouver
Strobel FA, Stammschulte T, Beeler PE. Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland. British Journal of Clinical Pharmacology. 2026;92(8):2797-2808. doi:10.1002/bcp.70543
BibTeX
@article{Strobel2026,
author = {Strobel, Fiona A and Stammschulte, Thomas and Beeler, Patrick E},
title = {Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
volume = {92},
number = {8},
pages = {2797--2808},
doi = {10.1002/bcp.70543}
}
EUVIMED